Takimoto Chris H has filed 12 insider transactions across 2 companies since March 2024.
Most recent transaction: a grant/award of 40400 shares of ALX ONCOLOGY HOLDINGS INC ($ALXO) on January 20, 2026.
Activity breakdown: 0 open-market purchases and 4 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 20, 2026 | ALX ONCOLOGY HOLDINGS INC | $ALXO | Takimoto Chris H | Not found | A | Stock option (right to buy) | 40400 | $0.00 | 40,400.0000 | 54,218,001 | 9999.99% | 0.07% |
| Jan. 21, 2025 | ALX ONCOLOGY HOLDINGS INC | $ALXO | Takimoto Chris H | Not found | A | Common Stock (right to buy) | 40400 | $0.00 | 40,400.0000 | 0 | 9999.99% | 0.00% |
| Sept. 13, 2024 | IGM Biosciences, Inc. | $IGMS | Takimoto Chris H | CHIEF MEDICAL OFFICER | S | Common Stock | 1487 | $11.54 | 154,331.0000 | 60,434,161 | 0.95% | 0.00% |
| July 19, 2024 | IGM Biosciences, Inc. | $IGMS | Takimoto Chris H | CHIEF MEDICAL OFFICER | A | Common Stock | 16250 | $0.00 | 155,818.0000 | 60,434,161 | 11.64% | 0.03% |
| July 19, 2024 | IGM Biosciences, Inc. | $IGMS | Takimoto Chris H | CHIEF MEDICAL OFFICER | D | Stock Option (right to buy) | 150000 | $0.00 | 0.0000 | 60,434,161 | 100.00% | 0.25% |
| July 19, 2024 | IGM Biosciences, Inc. | $IGMS | Takimoto Chris H | CHIEF MEDICAL OFFICER | A | Common Stock | 43750 | $0.00 | 139,568.0000 | 60,434,161 | 45.66% | 0.07% |
| June 14, 2024 | IGM Biosciences, Inc. | $IGMS | Takimoto Chris H | CHIEF MEDICAL OFFICER | S | Common Stock | 1570 | $7.58 | 95,818.0000 | 52,311,958 | 1.61% | 0.00% |
| May 15, 2024 | IGM Biosciences, Inc. | $IGMS | Takimoto Chris H | CHIEF MEDICAL OFFICER | A | Common Stock | 3000 | $5.02 | 97,388.0000 | 52,311,958 | 3.18% | 0.01% |
| March 13, 2024 | IGM Biosciences, Inc. | $IGMS | Takimoto Chris H | CHIEF MEDICAL OFFICER | S | Common Stock | 2889 | $9.88 | 96,923.0000 | 52,311,958 | 2.89% | 0.01% |
| March 14, 2024 | IGM Biosciences, Inc. | $IGMS | Takimoto Chris H | CHIEF MEDICAL OFFICER | S | Common Stock | 2535 | $10.17 | 94,388.0000 | 52,311,958 | 2.62% | 0.00% |
| March 12, 2024 | IGM Biosciences, Inc. | $IGMS | Takimoto Chris H | CHIEF MEDICAL OFFICER | A | Common Stock | 46250 | $0.00 | 99,812.0000 | 52,311,958 | 86.35% | 0.09% |
| March 12, 2024 | IGM Biosciences, Inc. | $IGMS | Takimoto Chris H | CHIEF MEDICAL OFFICER | A | Stock Option (right to buy) | 92500 | $0.00 | 92,500.0000 | 52,311,958 | 9999.99% | 0.18% |